Redhill Biopharma
Price & Volume
Stats
See more52W Range | $0.58-$2.79 |
Market Cap | $3.6M |
Shares Short | 19,996 |
Financials
See moreRevenue (12 Mos) | $286,000 |
Revenue Growth (YoY) | 58.6% |
Gross Profit (12 Mos) | $286,000 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 13 days ago
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
Yahoo Finance • 5 months ago
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Yahoo Finance • 8 months ago
RedHill Biopharma regains Nasdaq stockholders’ equity compliance
Yahoo Finance • 12 months ago
RedHill received Talicia licensing payments totaling $1.1 million
About
CEO | Mr. Dror Ben-Asher |
Address | 21 Ha?arba?a Street, Tel Aviv-Yafo, Israel, 6473921 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 13 |